NCT05180513

Brief Summary

The purpose of this study is to examine the comparative effectiveness of two technology-based Mindfulness Based Stress Reduction (MBSR) programs (one via video/teleconference and one via a smartphone app) for reducing worry, anxiety and/or related mental health effects of stress in members of identified underserved communities, which were highly impacted by the COVID-19 pandemic.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
270

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 14, 2021

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

May 19, 2021

Completed
8 months until next milestone

First Posted

Study publicly available on registry

January 6, 2022

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

September 20, 2024

Status Verified

September 1, 2024

Enrollment Period

3.1 years

First QC Date

May 19, 2021

Last Update Submit

September 19, 2024

Conditions

Keywords

Mindfulness Based Stress ReductionCommunity Based Research

Outcome Measures

Primary Outcomes (1)

  • Changes in Worry from baseline to mid-intervention at five weeks, post-intervention at nine weeks, and follow-ups to assess sustainability at one and three months following end of intervention

    A total score on the Penn State Worry Questionnaire \[PSWQ\], a scaled measure with total scores ranging from 16 to 80, in which higher scores indicate greater severity of worry

    21 Weeks: Change from Baseline score to score at mid-intervention, post-intervention, and follow-up scores at one month and three months past end of intervention

Secondary Outcomes (9)

  • Changes in Anxiety from baseline to mid-intervention at five weeks, post-intervention at nine weeks, and follow-ups to assess sustainability at one and three months following end of intervention

    21 Weeks: Change from Baseline score to score at mid-intervention, post-intervention, and follow-up scores at one month and three months past end of intervention

  • Changes in Perceived Stress from baseline to mid-intervention at five weeks, post-intervention at nine weeks, and follow-ups to assess sustainability at one and three months following end of intervention

    21 Weeks: Change from Baseline score to score at mid-intervention, post-intervention, and follow-up scores at one month and three months past end of intervention

  • Changes in Depression from baseline to mid-intervention at five weeks, post-intervention at nine weeks, and follow-ups to assess sustainability at one and three months following end of intervention

    Change from Baseline score to score at mid-intervention, post-intervention, and follow-up scores at one month and three months past end of intervention

  • Changes in Sleep Quality from baseline to mid-intervention at five weeks, post-intervention at nine weeks, and follow-ups to assess sustainability at one and three months following end of intervention

    21 weeks Change from Baseline score to score at mid-intervention, post-intervention, and follow-up scores at one month and three months past end of intervention

  • Changes in Loneliness from baseline to mid-intervention at five weeks, post-intervention at nine weeks, and follow-ups to assess sustainability at one and three months following end of intervention

    21 Weeks Change from Baseline score to score at mid-intervention, post-intervention, and follow-up scores at one month and three months past end of intervention

  • +4 more secondary outcomes

Study Arms (3)

Teleconference Mindfulness Intervention Group

OTHER

MBSR training program that has been adapted for use via Zoom teleconferencing and for cultural relevancy

Behavioral: Teleconference Mindfulness Intervention

Smartphone App Mindfulness Intervention Group

OTHER

MBSR training program that has been adapted for use via smartphone app and for cultural relevancy

Behavioral: Smartphone App Mindfulness Intervention

Waitlist Control Group

NO INTERVENTION

No intervention; control group

Interventions

The teleconference intervention is administered by a trained interventionist via Zoom and is based on a manual adapted from a traditional MBSR version. Practices and activities include meditations, mindful breathing exercises and movements, discussions, and reflections, which participants learn at weekly sessions and practice on their own throughout the week. To adapt the traditional MBSR program for the target community population, intervention materials were reviewed for feedback from community stakeholders, and modified according to their feedback.

Teleconference Mindfulness Intervention Group

The smartphone app intervention is administered through the app. The smartphone app aligns with the traditional MBSR format, but training and practice is done individually and independently by members of this group. To adapt the traditional MBSR program for the target community population, the app was tested by community stakeholders and modified according to their feedback.

Smartphone App Mindfulness Intervention Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years and older
  • Significant worry as per the Penn State Worry Questionnaire-Abbreviated \[PSWQ-A\]
  • Fluent in English
  • Reside in one of the local city zip codes, identified as underserved, and primarily African American, communities

You may not qualify if:

  • Severe depression as per Patient Health Questionnaire \[PHQ-9\]
  • Active suicidal intent as per PHQ-9 question 9
  • Diagnosis of psychosis, or bipolar disorder, or moderate or severe substance use disorder in the past month as per self report
  • Cognitive impairment as per (modified) Short Portable Mental Status Questionnaire \[SPMSQ\]
  • Currently receiving psychotherapy or behavioral counseling, including MBSR
  • Change in psychotropic medications within the last month as per self report
  • Unable to communicate in a way that would allow for participation in screenings or sessions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

State University of New York, University at Buffalo

Buffalo, New York, 14214, United States

Location

Study Officials

  • Yu-Ping Chang, PhD

    SUNY at Buffalo School of Nursing

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Professor and Associate Dean for Research and Scholarship

Study Record Dates

First Submitted

May 19, 2021

First Posted

January 6, 2022

Study Start

May 14, 2021

Primary Completion

June 30, 2024

Study Completion

June 30, 2024

Last Updated

September 20, 2024

Record last verified: 2024-09

Locations